|
| | Linagliptin MethyldiMer Basic information |
| Product Name: | Linagliptin MethyldiMer | | Synonyms: | Linagliptin MethyldiMer;8-[(3R)-3-aminopiperidin-1-yl]-1-[[4-[[2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]quinazolin-4-yl]methyl]-4-methyl-1H-quinazolin-2-yl]methyl]-7-but-2-ynyl-3-methylpurine-2,6-dione;8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-qui;Linagliptin Impurity T(Linagliptin Methyldimer);Linagliptin Methyldimer (~90%);8-((R)-3-aminopiperidin-1-yl)-1-((4-((2-((8-((R)-3-aminopiperidin-1-yl)- 7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-p;Linagliptin Dimer Imputiry 2;1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl- | | CAS: | 1418133-47-7 | | MF: | C50H56N16O4 | | MW: | 945.08 | | EINECS: | | | Product Categories: | | | Mol File: | 1418133-47-7.mol |  |
| | Linagliptin MethyldiMer Chemical Properties |
| Melting point | >142°C (dec.) | | density | 1.46±0.1 g/cm3(Predicted) | | storage temp. | Amber Vial, -20°C Freezer, Under inert atmosphere | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | pka | 10.01±0.20(Predicted) | | form | Solid | | color | White to Pale Yellow | | Stability: | Light Sensitive |
| | Linagliptin MethyldiMer Usage And Synthesis |
| Uses | Linagliptin Methyldimer inhibits dipeptidylpeptidase-IV (DPP-IV) and may be used in the treatment of type 2 diabetes. |
| | Linagliptin MethyldiMer Preparation Products And Raw materials |
|
